Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.
Drug Development and Real-world Clinical Needs Establish a New Era in Oncology Image Credits: MEDSIR Concern The United States, till now, has completed 321.4% of phase 2/3 clinical trials. The pe...
Fresenius Medical Care and CCINSHAE's Strategic Collaboration to Expand Innovative Therapy Image Credits: Fresenius Medical Care Announcement Fresenius Medical Care, a global provider of products...
Innocare’s Received Approval for a Clinical Trial in China Image Credits: BioWorld Announcement Innocare Pharma, a global biopharmaceutical company known for its advanced treatment for auto...
Brii Biosciences Signed a Licensing Agreement with Joincare Group Image Credits: Vietnam Investment Review Announcement Brii Biosciences, a global biotechnology company known for its excellent th...
Monte Rosa’s Solution in the Research Article Image Credits: Monte Rosa Therapeutics Inc. Publication Monte Rosa Therapeutics Inc., a global biotechnology company that has discovered molecu...
Japan’s 3D Bioprinted Human Tissu e Market is Seeking Growth by 2025-2032 Current Status Japan’s 3D Bioprinted Human Tissue Market is concentrating on opportunities and growth in the co...
SurgiBox Partnered with Ondatec Medical Announcement SurgiBox Inc., a leading medical technology company known for its excellent surgical services, has entered into a partnership agreem...
Pelthos Therapeutics Finalized the Merger Agreement with Channel Therapeutics Announcement Pelthos Therapeutics Inc., a global biopharmaceutical company known for marketing innovative therapeutic ...
Lixte Biotechnology Holdings Inc.'s Finalization of Securities in the Market Announcement Lixte Biotechnology Holdings, Inc., a pharmaceutical company, closed its private placement with valuable i...
Bluebird, a Center of Attraction What makes a popular equity firm approach a small biopharma firm? The Carlyle Group, along with SK Capital partner, intends to buy bluebird Bio for under $50 milli...
Speak with a healthcare analyst about your research, consulting, or platform needs.